We sought to identify peripheral blood markers associated with two immune-related factors—programmed cell death-ligand-2 (PD-L2) and indoleamine 2,3-dioxygenase-1 (IDO1)—that are expressed on tumor cells in primary lung adenocarcinoma (AD) specimens. Here, PDCD1LG2 is linked to lung adenocarcinoma.